Myungmonon Pharm finalizes issuing price for US$19.5m capital increase

11:31
[From the Scene] Immersive heritage exhibition opens in Gangneung, Las Vegas
10:51
Opposition leader faces sentencing hearing over allegedly suborning perjury this week
10:06
golden horse caption
09:41
Japan voices regret over S. Korea's non-attendance of Sado memorial
16:13
S. Korea not to attend Sado mine memorial: foreign ministry
16:01
Gyeongju blends old with new
16:01
[What to Play] Cozy songs to warm you up
16:01
[Weekender] Korea's traditional sauce culture gains global recognition
16:01
Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
16:01
At Gwangcheonok, try North Korean-style sundae gukbap

Myungmonon Pharm finalizes issuing price for US$19.5m capital increase

July 5, 2016 - 10:51 By 황유미

[DISCLOSURE] Myungmoon Pharm (017180) announced on July 5 that it has finalized the price of its new stocks at 4,995 won (US$4.35) per share. The company decided to issue 4.49 million shares for capital increase for equipment investment in May.

황유미